ASCEND BY NTHRYS
Research Abroad Products

Genetics Project Topics

Browse all focused areas across all project categories under this field.

Showing 1153–1164 of 2020 project topics
ALL Genetic Risk Stratification
Developing integrated genomic and cytogenetic risk stratification incorporating BCR-ABL1, ETV6-RUNX1, and ploidy for treatment intensity decisions in ALL.
Genetic Basis of Lymphoma and Leukemia Click to view more details →
Clonal Evolution in Lymphoma Relapse
Tracking clonal dynamics and genomic evolution between diagnosis and relapse samples for understanding resistance mechanisms in lymphoma.
Genetic Basis of Lymphoma and Leukemia Click to view more details →
TP53 Mutation Profiling Software for Leukemia Prognosis
A diagnostic SaaS platform that sequences and analyzes TP53 mutations in acute leukemia samples to predict treatment response and patient outcomes. This enables oncologists to stratify patients for targeted therapies, improving clinical trial enrollment and personalized medicine adoption rates.
Genetic Basis of Lymphoma and Leukemia Click to view more details →
MYC Translocation Detection Kit for Lymphoma Subtyping
A commercialized molecular diagnostics kit that identifies MYC, BCL2, and BCL6 translocations to classify aggressive lymphoma subtypes and guide treatment selection. This product captures market share in the $2B+ hematologic malignancy diagnostics sector by enabling faster turnaround times.
Genetic Basis of Lymphoma and Leukemia Click to view more details →
JAK2 and FLT3 ITD Mutation Testing Platform
An integrated laboratory information system that performs high-throughput JAK2 V617F and FLT3-ITD mutation screening for myeloproliferative and acute myeloid leukemia diagnosis. The platform generates recurring revenue through per-test pricing and partnerships with clinical laboratories nationwide.
Genetic Basis of Lymphoma and Leukemia Click to view more details →
NOTCH1 and PTEN Loss-of-Function Analysis Tool
A bioinformatics tool that integrates genomic sequencing data to detect NOTCH1 and PTEN mutations in T-cell acute lymphoblastic leukemia for early intervention. This addresses a critical need in pediatric oncology for risk stratification, opening licensing opportunities with hospital systems and research institutions.
Genetic Basis of Lymphoma and Leukemia Click to view more details →
Complex Karyotype Interpretation Engine for Chronic Lymphocytic Leukemia
An AI-powered analysis platform that interprets del(13q), del(11q), del(17p), and complex karyotypes to predict CLL progression and treatment resistance. The tool monetizes through subscription licensing and integration into existing laboratory workflows, reducing manual interpretation time by 70%.
Genetic Basis of Lymphoma and Leukemia Click to view more details →
Minimal Residual Disease Detection Assay Development Service
A contract research service offering custom next-generation sequencing assays to detect MRD in lymphomas and leukemias at minimal detection thresholds. This service generates high-margin revenue through per-assay fees and establishes long-term partnerships with pharmaceutical companies conducting clinical trials.
Genetic Basis of Lymphoma and Leukemia Click to view more details →
eQTL Mapping in Relevant Disease Tissues
Performing expression QTL mapping in disease-relevant tissues using GTEx and disease-specific datasets for identifying regulatory mechanisms of GWAS signals.
Gene Expression and Genetics Integration Click to view more details →
Splicing QTL Detection in Disease Context
Mapping splicing quantitative trait loci to identify genetic variants controlling alternative splicing in disease-relevant tissues.
Gene Expression and Genetics Integration Click to view more details →
Single Cell eQTL Mapping for Cell Type Resolution
Applying single cell RNA sequencing for cell type-specific eQTL mapping to identify regulatory variants acting in specific cell populations.
Gene Expression and Genetics Integration Click to view more details →
Genetic Colocalization of eQTL and GWAS Signals
Testing colocalization between eQTL and disease GWAS signals using COLOC and enloc methods for prioritizing causal gene mediators of disease risk.
Gene Expression and Genetics Integration Click to view more details →